Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Additional funding for UK prostate cancer research:

This article was originally published in Clinica

Executive Summary

The UK government has injected an extra £1 million ($1.6 million) in funding for research into diagnosis and treatment of prostate cancer. An expert review group, co-ordinated by the Medical Research Council, has also been set up to identify the key areas of prostate cancer research. However, Jonathan Waxman, chairman of the UK Prostate Cancer Charity, said "much more funding will be required" in order to tackle the disease. Over 10,000 men die from the disease in the UK each year and 20,000 new cases are diagnosed annually. The rates of incidence are expected to increase by almost 50% by 2021.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT075624

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel